Skip to content

A multicenter, prospective observational study of treatment and prognosis in patients with primary small bowel cancer

A multicenter, prospective observational study of treatment and prognosis in patients with primary small bowel cancer - NHOD-SBC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030361
Enrollment
60
Registered
2017-12-25
Start date
2017-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small bowel cancer

Interventions

None listed

Sponsors

National Hospital Organization Okayama Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)With primary small bowel cancer excluding newly-diagnosed duodenal papillary carcinoma (2)Confirmed pathologically as adenocarcinoma (3)Provided written consent by their free will

Exclusion criteria

Exclusion criteria: (1)Whose treatment contents cannot be grasped (2)Where it has active double cancer and cannot determine the cause that affects prognosis

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Progression-free survival. Incidence of adverse events.

Countries

Japan

Contacts

Public ContactHaruhiro Yamashita

NHO Okayama Medical Center Internal Medicine

yamashita.haruhiro.ud@mail.hosp.go.jp0862949911

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026